Evaluation of Efficacy and Safety of the Dosage Adjustment of Aprovel® (Irbesartan) in Hypertensive Outpatients in Current Clinical Practice

This study has been completed.

Study NCT00564187 Information provided by Sanofi-Aventis

First Received: November 20, 2007 Last Updated: November 27, 2007 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	December 2004
Estimated Primary Completion Date:	No date given